Back
Monopar Therapeutics Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
MNPR
Monopar Therapeutics
Last Price:
$36.90
Seasonality Move:
-14.17%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and MNPR is experiencing slight buying pressure.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.86 | Buy |
| 20-day SMA: | 34.79 | Buy |
| 50-day SMA: | 37.86 | Buy |
| 200-day SMA: | 17.05 | Buy |
| 8-day EMA: | 38.75 | Buy |
| 20-day EMA: | 37.13 | Buy |
| 50-day EMA: | 35.15 | Buy |
| 200-day EMA: | 21.74 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.01 | Buy |
| Relative Strength Index (14 RSI): | 56.65 | Buy |
| Chaikin Money Flow: | 2380 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.07 - 39.49) | Buy |
| Bollinger Bands (100): | (19.65 - 39.65) | Buy |
Monopar Therapeutics Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 40.33 while MNPR 8-day simple moving average is 39.86, which is a Buy signal.
-
The stock price of MNPR is 40.33 while Monopar Therapeutics 20-day SMA is 34.79, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 37.86 while MNPR share price is 40.33, making it a Buy technically.
-
MNPR stock price is 40.33 and Monopar Therapeutics 200-day simple moving average is 17.05, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Sell
48
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a SellThe current Monopar Therapeutics [MNPR] share price is $40.33. The Score for MNPR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
212.9M
Price in USD:
40.33
Share Volume:
17.7K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Sell
48
Monopar Therapeutics (MNPR)
is a Sell
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 40.33 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 40.33 while MNPR 8-day exponential moving average is 38.75, which is a Buy signal.
-
The stock price of MNPR is 40.33 while Monopar Therapeutics 20-day EMA is 37.13, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 35.15 while MNPR share price is 40.33, making it a Buy technically.
-
MNPR stock price is 40.33 and Monopar Therapeutics 200-day simple moving average is 21.74, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is 1.01, suggesting Monopar Therapeutics is a Buy
-
Monopar Therapeutics Relative Strength Index (RSI) is 56.65, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (30.07 - 39.49), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (19.65 - 39.65), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.